Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation. - Dimou, Anastasios; Ou, Sai-Hong I.; Doebele, Robert C. (JCO Precision Oncology, 2019)